Stoxx Europe 50
4.997,41
PKT
+20,76
PKT
+0,42
%
Werbung
Analysen zu Stoxx Europe 50-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 26.06.25 | Shell (ex Royal Dutch Shell) Overweight | JP Morgan Chase & Co. | |
| 26.06.25 | Rheinmetall Overweight | JP Morgan Chase & Co. | |
| 26.06.25 | Prosus Overweight | JP Morgan Chase & Co. | |
| 26.06.25 | AstraZeneca Outperform | Bernstein Research | |
| 26.06.25 | Prosus Buy | UBS AG | |
| 26.06.25 | Deutsche Telekom Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 26.06.25 | ASML NV Hold | Jefferies & Company Inc. | |
| 25.06.25 | ABB (Asea Brown Boveri) Sell | Deutsche Bank AG | |
| 25.06.25 | RELX Overweight | JP Morgan Chase & Co. | |
| 25.06.25 | Unilever Overweight | JP Morgan Chase & Co. | |
| 25.06.25 | Unilever Sell | UBS AG | |
| 25.06.25 | Richemont Overweight | JP Morgan Chase & Co. | |
| 25.06.25 | SAFRAN Overweight | Barclays Capital | |
| 25.06.25 | Airbus Overweight | Barclays Capital | |
| 24.06.25 | BBVA Outperform | RBC Capital Markets | |
| 24.06.25 | Nestlé Neutral | UBS AG | |
| 24.06.25 | SAP Buy | Jefferies & Company Inc. | |
| 24.06.25 | Prosus Buy | Deutsche Bank AG | |
| 24.06.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 24.06.25 | Airbus Buy | Deutsche Bank AG | |
| 24.06.25 | AB InBev SA-NV (Anheuser-Busch InBev) Buy | UBS AG | |
| 24.06.25 | Novo Nordisk Buy | UBS AG | |
| 24.06.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 24.06.25 | Prosus Overweight | JP Morgan Chase & Co. | |
| 24.06.25 | ABB (Asea Brown Boveri) Underperform | Bernstein Research | |
| 23.06.25 | Deutsche Telekom Buy | UBS AG | |
| 23.06.25 | Rheinmetall Kaufen | DZ BANK | |
| 23.06.25 | ASML NV Market-Perform | Bernstein Research | |
| 23.06.25 | EssilorLuxottica Market-Perform | Bernstein Research | |
| 23.06.25 | Schneider Electric Outperform | Bernstein Research | |
| 23.06.25 | LOréal Sell | Deutsche Bank AG | |
| 23.06.25 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 23.06.25 | Airbus Kaufen | DZ BANK | |
| 23.06.25 | Prosus Buy | UBS AG | |
| 23.06.25 | Novo Nordisk Overweight | Barclays Capital | |
| 23.06.25 | Rolls-Royce Overweight | JP Morgan Chase & Co. | |
| 23.06.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 23.06.25 | BNP Paribas Neutral | JP Morgan Chase & Co. | |
| 23.06.25 | UBS Overweight | JP Morgan Chase & Co. | |
| 20.06.25 | Novo Nordisk Buy | UBS AG |